Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SLAM DRILLS MORE COPPER MINERALIZATION AT GOODWIN (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neovasc Inc. NVCN

Healthcare Medical Instruments & Supplies
Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter... see more

Recent & Breaking News (NDAQ:NVCN)

Neovasc Inc. Investor Update

Newsfile January 13, 2020

Neovasc Inc. Investor Update

GlobeNewswire January 13, 2020

Neovasc Announces Closing of $10 Million Registered Direct Offering Priced At-The-Market

Newsfile January 6, 2020

Neovasc Announces Closing of $10 Million Registered Direct Offering Priced At-The-Market

GlobeNewswire January 6, 2020

IIROC Trade Resumption - NVCN

Canada NewsWire January 2, 2020

Neovasc Announces $10 Million Registered Direct Offering Priced At-The-Market

GlobeNewswire January 2, 2020

Neovasc Announces $10 Million Registered Direct Offering Priced At-The-Market

Newsfile January 2, 2020

IIROC Trading Halt - NVCN

Canada NewsWire January 2, 2020

Neovasc Submits Premarket Approval Application to FDA for Neovasc Reducer(TM)

Newsfile December 31, 2019

Neovasc Submits Premarket Approval Application to FDA for Neovasc Reducer(TM)

GlobeNewswire December 31, 2019

Neovasc Reducer(TM) Featured In National Geographic Magazine

Newsfile December 17, 2019

Neovasc Reducer(TM) Featured In National Geographic Magazine

GlobeNewswire December 17, 2019

Neovasc Named Finalist in Questex's Fierce Innovation Awards LifeSciences Edition 2019

GlobeNewswire December 4, 2019

Neovasc Reducer(TM) Featured In FOCUS Magazine

Newsfile November 26, 2019

Neovasc Reducer(TM) Featured In FOCUS Magazine

GlobeNewswire November 26, 2019

Neovasc Reducer(TM) Featured During Therapy Development Program in Coburg and Session at Maria Cecilia Hospital in Cotignola

GlobeNewswire November 22, 2019

Neovasc Tiara(TM) Progress Highlighted at PCR London Valves 2019

Newsfile November 19, 2019

Neovasc Tiara(TM) Progress Highlighted at PCR London Valves 2019

GlobeNewswire November 19, 2019

Neovasc Reducer(TM) Therapy for Refractory Angina Exceeds 200th Patient Milestone in Germany

Newsfile November 12, 2019

Neovasc Reducer(TM) Therapy for Refractory Angina Exceeds 200th Patient Milestone in Germany

GlobeNewswire November 12, 2019